-
-
-
-
-
-
-
Adial Pharmaceuticals Reports Second Quarter 2023 Financial ResultsĀ and Provides Business Update
-
-
-
-
-
-
-
Sysorex Elects Nasdaq-Listed Company CEO William Stilley to Board of Directors
-
-
-
-
-
-
-
Adial Pharmaceuticals Schedules Business Update Conference Call to Discuss Planned Acquisition of Purnovate and other Recent Developments
-
-
-
-
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

